Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when MD files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MD Pediatrix Medical Group, Inc. 8-K

Pediatrix Medical Group announces General Counsel transition; Moore to depart Oct 31

Filed July 24, 2026 · Period ending July 21, 2026 · ~1 min read

2 key changes

Key Changes

  • medium

    Mary Ann E. Moore, EVP, General Counsel, Chief Administrative Officer and Secretary, will depart effective October 31, 2026 after serving in an advisory role through the transition period. Separation structured as termination without cause under her employment agreement.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • medium

    David Haddock appointed as Executive Vice President, General Counsel and Secretary. The filing does not disclose his background, prior experience, start date, or compensation terms.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →

Summary

Pediatrix Medical Group disclosed a planned transition in its General Counsel role. Mary Ann E. Moore, who serves as Executive Vice President, General Counsel, Chief Administrative Officer and Secretary, will depart the company effective October 31, 2026. She will remain in an advisory capacity through that date to facilitate the transition.

The separation is structured as a termination without cause under her employment agreement, entitling her to specified severance benefits. The company has appointed David Haddock as Executive Vice President, General Counsel and Secretary to succeed Moore. The filing provides no information about Haddock's background, prior legal or corporate experience, start date, or compensation arrangements.

For a public company General Counsel role overseeing legal, compliance, and administrative functions, the absence of disclosed credentials or terms is notable but not uncommon in initial announcements. Retail holders should watch for subsequent disclosure of Haddock's qualifications and compensation in upcoming proxy or compensation filings.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Jul 27, 2026 · How we verify